Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant aspirin versus placebo in resected colorectal cancer after chemotherapy
ACTRN12614000513617Phase 3Completed
- Sponsor
- Australasian Gastro-Intestinal Trials Group
- Start
- Aug 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in colorectal cancer (CRC) comparing Aspirin with Placebo (2 arms). Primary endpoint: Disease-free survival. Started Aug 2014; status: completed.
02
Drugs
aspirin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ACTRN12614000513617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000513617.